These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34122631)

  • 1. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
    Li Y; Hua K; Jin J; Fang L
    Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD.
    Wu C; Zhao A; Tan T; Wang Y; Shen Z
    Exp Ther Med; 2019 Jul; 18(1):550-558. PubMed ID: 31258693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.
    Lee SJ; Jeong JH; Lee J; Park HY; Jung JH; Kang J; Kim EA; Park NJ; Park JY; Lee IH; Chae YS
    Medicine (Baltimore); 2021 Apr; 100(14):e25270. PubMed ID: 33832090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
    Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
    BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
    Li D; Hu J; Song H; Xu H; Wu C; Zhao B; Xie D; Wu T; Zhao J; Fang L
    Am J Transl Res; 2017; 9(5):2276-2285. PubMed ID: 28559978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.
    Zhang X; Ma G; Liu J; Zhang Y
    Oncol Lett; 2017 Oct; 14(4):4805-4811. PubMed ID: 29085483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.
    Si C; Yu Q; Yao Y
    Exp Ther Med; 2018 May; 15(5):4515-4521. PubMed ID: 29731835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-182 targets FOXF2 to promote the development of triple-negative breast cancer.
    Yu J; Shen W; Gao B; Zhao H; Xu J; Gong B
    Neoplasma; 2017; 64(2):209-215. PubMed ID: 28043147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.
    Huang R; Li J; Pan F; Zhang B; Yao Y
    Am J Transl Res; 2020; 12(1):32-44. PubMed ID: 32051735
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
    Liu H; Wang G
    Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH
    Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.
    Chen FY; Zhou ZY; Zhang KJ; Pang J; Wang SM
    Cancer Cell Int; 2020; 20():508. PubMed ID: 33088216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.